Abstract
Purpose :
Ophthalmologists are increasingly utilizing intracameral (IC) antibiotics for prophylaxis during cataract surgery. We performed a retrospective chart review to evaluate the rate of acute postoperative endophthalmitis (POE) after cataract surgery using IC moxifloxacin at a tertiary academic center.
Methods :
International Review Board approval was obtained from the University of Kansas Medical Center prior to the study. We conducted a retrospective chart review of phacoemulsification surgeries with or without intraocular lens placement. Surgeries were performed as either standalone procedures or in combination with other ophthalmic surgeries. The surgeries were performed by six cataract surgeons at a single institution between February 1, 2018 and August 10, 2020. All patients included in analysis received IC moxifloxacin during surgery. Patients who underwent combination surgeries received postoperative topical antibiotics in addition to IC moxifloxacin, while those who underwent standalone cataract surgery received IC moxifloxacin alone. Patients who did not receive IC moxifloxacin due to a preexisting fluoroquinolone allergy were excluded from analysis. Analysis included the rate of acute POE following all surgeries and the occurrence of any adverse reactions to IC moxifloxacin administration in those with a preexisting fluoroquinolone allergy.
Results :
2,359 eyes underwent cataract surgery (standalone and combination surgeries combined) over the study period. Zero cases of acute POE were observed after all 2,359 surgeries (0%). There were no reports of adverse reactions to IC moxifloxacin administration in the 43 patients identified as having a preexisting fluoroquinolone allergy (72 surgeries total), despite the most commonly listed preexisting allergic reaction to fluoroquinolones being “rash or itching.”
Conclusions :
Our academic center’s rate of acute POE after cataract surgery using IC moxifloxacin is 0%. No adverse reactions to IC moxifloxacin administration were reported in patients with preexisting fluoroquinolone allergy. Importantly, no cases of acute POE were identified in patients who underwent standalone cataract surgery using IC moxifloxacin without the addition of postoperative topical antibiotics.
This is a 2021 ARVO Annual Meeting abstract.